The year 2026 has introduced a radical new contender to the PSC pipeline: Endogenous RNA Editing. Rather than permanently altering DNA, new investigational therapies like AX-0810 are designed to "instruct" the body's own enzymes to temporarily edit RNA sequences. In 2026, this technology is being tested to modulate the NTCP protein, which is responsible for transporting bile acids into liver...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
thai
English
French
Spanish
Portuguese
Italiano
Portuguese (Brazil)
china